Mast cell degranulating peptide (28-49)

CC[C@H](C)[C@H](N)C(N[C@@H](CCCCN)C(N[C@@H](CS)C(N[C@@H](CC(N)=O)C(N[C@@H](CS)C(N[C@@H](CCCCN)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC1=CN=CN1)C(N[C@@H](C(C)C)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CCCCN)C(N2[C@@H](CCC2)C(N[C@H](C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CS)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCCN)C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CS)C(NCC(N[C@@H](CCCCN)C(N[C@H](C(N)=O)CC(N)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)CC3=CN=CN3)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O

[1]Ahnert G, et al. Investigations on the mechanism of cyclic guanosine monophosphate increase due to depolarizing agents as studied with sea anemone toxin II in mouse cerebellar slices. Naunyn Schmiedebergs Arch Pharmacol. 1979 Jun;307 (2) :159-66.